Adam Laponis
Chief Financial Officer at Twist Bioscience. Based in South San Francisco, California.
- Rank
- 6764th of 14,452
- Companies held
- 1
- Largest holding
- TWST, 100.0% of total
- Latest SEC filing
- Nov 16, 2026
What the $14.1M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Twist Bioscience TWST Common Stock | Directly | 126,329 | $111.62 | $14.1M | 100.0% | Form 4, Nov 16, 2026 |
Share counts are the amounts Adam Laponis reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 16, 2026 | Sold | TWST | 6,359 | $103.69 | $659K | View |
| Oct 9, 2026 | Sold | TWST | 2,462 | $156.30 | $385K | View |
| Oct 2, 2026 | Sold | TWST | 8,057 | $188.88 | $1.5M | View |
| Aug 21, 2026 | Sold | TWST | 1,965 | $139.07 | $273K | View |
| Jul 9, 2026 | Sold | TWST | 2,399 | $94.33 | $226K | View |
| May 29, 2026 | Sold | TWST | 4,000 | $70.00 | $280K | View |
| May 21, 2026 | Sold | TWST | 2,019 | $53.26 | $108K | View |
| Apr 17, 2026 | Sold | TWST | 4,000 | $60.00 | $240K | View |
| Apr 14, 2026 | Sold | TWST | 3,000 | $55.00 | $165K | View |
| Apr 9, 2026 | Sold | TWST | 2,597 | $49.89 | $130K | View |
| Feb 23, 2026 | Sold | TWST | 2,085 | $46.71 | $97K | View |
| Feb 12, 2026 | Sold | TWST | 7,000 | $50.00 | $350K | View |
| Jan 13, 2026 | Sold | TWST | 3,000 | $40.00 | $120K | View |
| Jan 9, 2026 | Sold | TWST | 2,738 | $35.26 | $97K | View |
| Nov 21, 2025 | Sold | TWST | 887 | $26.50 | $24K | View |
| Oct 30, 2025 | Sold | TWST | 5,517 | $31.44 | $173K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 6761 | Belgacem Chariag See Remarks, Ecovyst. Tulsa, OK | $14.1M |
| 6762 | Timothy White President, Alamar Biosciences. Fremont, CA | $14.1M |
| 6763 | Srinivas Tallapragada Chief Eng/Cust Success Officer, Salesforce. New York, NY | $14.1M |
| 6764 | Adam Laponis Chief Financial Officer, Twist Bioscience. South San Francisco, CA | $14.1M |
| 6765 | Scot Frazier Rogers Chief Administrative Officer, Teradata. San Diego, CA | $14.1M |
| 6766 | Shannon Parisotto CEVP, Disc & Safety Assessment, Charles River Laboratories International. Wilmington, MA | $14.1M |
| 6767 | Dein Boyle COO, Victorias Secret &. Reynoldsburg, OH | $14.1M |
Other Twist Bioscience insiders
All TWST insiders- Emily M. Leproust$74.9MChief Executive Officer. #1870 overall
- William Banyai$38.5MSee Remark. #3091 overall
- Patrick John Finn$26.7MPresident and COO. #4149 overall
- Paula Green$14.3MSVP of Human Resources. #6694 overall
- Keith Crandell$11.6MDirector. #7570 overall
- Dennis Cho$9.7MSee Remarks. #8959 overall
Questions
How much stock does Adam Laponis own?
Adam Laponis holds $14,100,843 in listed stock based on SEC filings and current prices, mostly Twist Bioscience (TWST). That ranks 6764th on the Stock Rich List.
Is this Adam Laponis's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Adam Laponis last buy or sell stock?
The most recent open-market trade on file is a sale of 6,359 TWST shares on Nov 16, 2026 at $103.69.